Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

GLIS rearrangements in thyroid nodules: A key to preoperative diagnosis of hyalinizing trabecular tumor.

Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2019 Sep;127(9):560-566. doi: 10.1002/cncy.22163. Epub 2019 Aug 2. Review.

PMID:
31373774
2.

Integrating next-generation sequencing to endoscopic retrograde cholangiopancreatography (ERCP)-obtained biliary specimens improves the detection and management of patients with malignant bile duct strictures.

Singhi AD, Nikiforova MN, Chennat J, Papachristou GI, Khalid A, Rabinovitz M, Das R, Sarkaria S, Ayasso MS, Wald AI, Monaco SE, Nalesnik M, Ohori NP, Geller D, Tsung A, Zureikat AH, Zeh H, Marsh JW, Hogg M, Lee K, Bartlett DL, Pingpank JF, Humar A, Bahary N, Dasyam AK, Brand R, Fasanella KE, McGrath K, Slivka A.

Gut. 2019 Apr 10. pii: gutjnl-2018-317817. doi: 10.1136/gutjnl-2018-317817. [Epub ahead of print]

3.

Benign call rate and molecular test result distribution of ThyroSeq v3.

Ohori NP, Landau MS, Carty SE, Yip L, LeBeau SO, Manroa P, Seethala RR, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2019 Mar;127(3):161-168. doi: 10.1002/cncy.22088. Epub 2018 Dec 18.

PMID:
30561907
4.

Percutaneous computed tomography-guided biopsy performed by thoracic surgeons in 955 patients: A paradigm shift in image-guided thoracic procedures.

Welborn SL, Ohori NP, Nason KS, Pennathur A, Awais O, Christie NA, Luketich JD, Schuchert MJ.

J Thorac Cardiovasc Surg. 2018 Nov 13. pii: S0022-5223(18)32939-8. doi: 10.1016/j.jtcvs.2018.09.125. [Epub ahead of print]

PMID:
30553595
5.

Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.

McHale T, Ohori NP, Cieply KM, Sherer C, Bastacky SI.

Diagn Cytopathol. 2019 Apr;47(4):282-288. doi: 10.1002/dc.24108. Epub 2018 Nov 12.

PMID:
30417563
6.

Cancer risk and clinicopathological characteristics of thyroid nodules harboring thyroid-stimulating hormone receptor gene mutations.

Mon SY, Riedlinger G, Abbott CE, Seethala R, Ohori NP, Nikiforova MN, Nikiforov YE, Hodak SP.

Diagn Cytopathol. 2018 May;46(5):369-377. doi: 10.1002/dc.23915. Epub 2018 Mar 8.

PMID:
29516685
7.

Incidental Diagnosis of Parathyroid Lesions by Preoperative Use of Next-Generation Molecular Testing.

Bo W, Schoedel KE, Carty SE, Radkay LA, Ohori NP, Nikiforov YE, Nikiforova MN, Yip L.

World J Surg. 2018 Sep;42(9):2840-2845. doi: 10.1007/s00268-018-4548-3.

PMID:
29470700
8.

Correct extent of thyroidectomy is poorly predicted preoperatively by the guidelines of the American Thyroid Association for low and intermediate risk thyroid cancers.

Dhir M, McCoy KL, Ohori NP, Adkisson CD, LeBeau SO, Carty SE, Yip L.

Surgery. 2018 Jan;163(1):81-87. doi: 10.1016/j.surg.2017.04.029. Epub 2017 Nov 8.

PMID:
29128185
9.

Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia.

Singhi AD, McGrath K, Brand RE, Khalid A, Zeh HJ, Chennat JS, Fasanella KE, Papachristou GI, Slivka A, Bartlett DL, Dasyam AK, Hogg M, Lee KK, Marsh JW, Monaco SE, Ohori NP, Pingpank JF, Tsung A, Zureikat AH, Wald AI, Nikiforova MN.

Gut. 2018 Dec;67(12):2131-2141. doi: 10.1136/gutjnl-2016-313586. Epub 2017 Sep 28.

10.

A diagnostically difficult case of a cellular pleural fluid: Morphology, immunohistochemistry, and fluorescence in situ hybridization study.

Wang M, Samankan S, Bhalla A, Ohori NP, Frisch NK.

Cytojournal. 2017 Jul 24;14:18. doi: 10.4103/cytojournal.cytojournal_54_16. eCollection 2017. No abstract available.

11.

Critical diagnoses in cytopathology: Experience at a large medical center.

Xing J, Seigh L, Monaco SE, Ohori NP, Yousem SA, Amin R, Pantanowitz L.

Cancer Cytopathol. 2017 Sep;125(9):726-730. doi: 10.1002/cncy.21896. Epub 2017 Jul 13.

12.

The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.

Ohori NP, Wolfe J, Carty SE, Yip L, LeBeau SO, Berg AN, Schoedel KE, Nikiforov YE, Seethala RR.

Cancer Cytopathol. 2017 Sep;125(9):692-700. doi: 10.1002/cncy.21892. Epub 2017 Jul 5.

13.

Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.

Ohori NP, Seethala RR, Nikiforov YE.

Cancer Cytopathol. 2017 Apr;125(4):292-293. doi: 10.1002/cncy.21830. Epub 2017 Feb 7. No abstract available.

14.

Preoperative detection of RAS mutation may guide extent of thyroidectomy.

Patel SG, Carty SE, McCoy KL, Ohori NP, LeBeau SO, Seethala RR, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2017 Jan;161(1):168-175. doi: 10.1016/j.surg.2016.04.054. Epub 2016 Nov 15.

15.

Committee I: Indications for pulmonary cytology sampling methods.

Michael CW, Hoda RS, Saqi A, Kazakov J, Elsheikh T, Azar N, Ohori NP.

Diagn Cytopathol. 2016 Dec;44(12):1010-1023. doi: 10.1002/dc.23620. Epub 2016 Oct 18.

PMID:
27753244
16.

Changes in Resident Graduate Characteristics in a Large Pathology Training Program, 1994 to 2013.

Ohori NP, Radkay LA, Macpherson TA, Yousem SA, Schoedel KE.

Acad Pathol. 2016 Apr 19;3:2374289516643543. doi: 10.1177/2374289516643543. eCollection 2016 Jan-Dec.

17.

Epithelioid Hemangioendothelioma: a Rare Primary Thyroid Tumor with Confirmation of WWTR1 and CAMTA1 Rearrangements.

Shah AA, Ohori NP, Yip L, Coyne C, Antonescu CR, Seethala RR.

Endocr Pathol. 2016 Jun;27(2):147-52. doi: 10.1007/s12022-016-9428-5.

PMID:
27026033
18.

Endoscopic ultrasound-guided FNA and ProCore biopsy in sampling pancreatic and intra-abdominal masses.

Dwyer J, Pantanowitz L, Ohori NP, Pai RK, Vrbin C, Brand RE, Monaco SE.

Cancer Cytopathol. 2016 Feb;124(2):110-21. doi: 10.1002/cncy.21623. Epub 2015 Oct 2.

19.

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Thyroid. 2015 Nov;25(11):1217-23. doi: 10.1089/thy.2015.0305. Epub 2015 Sep 10.

20.

Tumor genotype determines phenotype and disease-related outcomes in thyroid cancer: a study of 1510 patients.

Yip L, Nikiforova MN, Yoo JY, McCoy KL, Stang MT, Armstrong MJ, Nicholson KJ, Ohori NP, Coyne C, Hodak SP, Ferris RL, LeBeau SO, Nikiforov YE, Carty SE.

Ann Surg. 2015 Sep;262(3):519-25; discussion 524-5. doi: 10.1097/SLA.0000000000001420.

21.

Significance of what is not sampled: Characteristics of thyroid nonmicrocarcinomas (>1.0 cm) that were not targeted.

Schoedel KE, Wolfe J, Hodak SP, Lebeau SO, Yip L, Carty SE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2015 Nov;123(11):678-83. doi: 10.1002/cncy.21603. Epub 2015 Aug 4.

22.

Adequacy of core needle biopsy specimens and fine-needle aspirates for molecular testing of lung adenocarcinomas.

Schneider F, Smith MA, Lane MC, Pantanowitz L, Dacic S, Ohori NP.

Am J Clin Pathol. 2015 Feb;143(2):193-200; quiz 306. doi: 10.1309/AJCPMY8UI7WSFSYY.

PMID:
25596245
23.

Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

Nikiforov YE, Carty SE, Chiosea SI, Coyne C, Duvvuri U, Ferris RL, Gooding WE, Hodak SP, LeBeau SO, Ohori NP, Seethala RR, Tublin ME, Yip L, Nikiforova MN.

Cancer. 2014 Dec 1;120(23):3627-34. doi: 10.1002/cncr.29038. Epub 2014 Sep 10.

24.

Thyroid nodules with KRAS mutations are different from nodules with NRAS and HRAS mutations with regard to cytopathologic and histopathologic outcome characteristics.

Radkay LA, Chiosea SI, Seethala RR, Hodak SP, LeBeau SO, Yip L, McCoy KL, Carty SE, Schoedel KE, Nikiforova MN, Nikiforov YE, Ohori NP.

Cancer Cytopathol. 2014 Dec;122(12):873-82. doi: 10.1002/cncy.21474. Epub 2014 Aug 12.

25.

Preoperative GNAS and KRAS testing in the diagnosis of pancreatic mucinous cysts.

Singhi AD, Nikiforova MN, Fasanella KE, McGrath KM, Pai RK, Ohori NP, Bartholow TL, Brand RE, Chennat JS, Lu X, Papachristou GI, Slivka A, Zeh HJ, Zureikat AH, Lee KK, Tsung A, Mantha GS, Khalid A.

Clin Cancer Res. 2014 Aug 15;20(16):4381-9. doi: 10.1158/1078-0432.CCR-14-0513. Epub 2014 Jun 17.

26.

A clinical algorithm for fine-needle aspiration molecular testing effectively guides the appropriate extent of initial thyroidectomy.

Yip L, Wharry LI, Armstrong MJ, Silbermann A, McCoy KL, Stang MT, Ohori NP, LeBeau SO, Coyne C, Nikiforova MN, Bauman JE, Johnson JT, Tublin ME, Hodak SP, Nikiforov YE, Carty SE.

Ann Surg. 2014 Jul;260(1):163-8. doi: 10.1097/SLA.0000000000000215.

PMID:
24901361
27.

PAX8/PPARγ rearrangement in thyroid nodules predicts follicular-pattern carcinomas, in particular the encapsulated follicular variant of papillary carcinoma.

Armstrong MJ, Yang H, Yip L, Ohori NP, McCoy KL, Stang MT, Hodak SP, Nikiforova MN, Carty SE, Nikiforov YE.

Thyroid. 2014 Sep;24(9):1369-74. doi: 10.1089/thy.2014.0067. Epub 2014 Jul 16.

28.

Ancillary Studies in Thyroid Cytopathology.

Ohori NP, Schoedel KE.

Surg Pathol Clin. 2014 Mar;7(1):47-60. doi: 10.1016/j.path.2013.10.001. Epub 2013 Nov 25. Review.

PMID:
26839268
29.

Thyroid nodules (≥4 cm): can ultrasound and cytology reliably exclude cancer?

Wharry LI, McCoy KL, Stang MT, Armstrong MJ, LeBeau SO, Tublin ME, Sholosh B, Silbermann A, Ohori NP, Nikiforov YE, Hodak SP, Carty SE, Yip L.

World J Surg. 2014 Mar;38(3):614-21. doi: 10.1007/s00268-013-2261-9.

PMID:
24081539
30.

Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.

Mehta RS, Carty SE, Ohori NP, Hodak SP, Coyne C, LeBeau SO, Tublin ME, Stang MT, Johnson JT, McCoy KL, Nikiforova MN, Nikiforov YE, Yip L.

Surgery. 2013 Oct;154(4):730-6; discussion 736-8. doi: 10.1016/j.surg.2013.05.015.

PMID:
24074409
31.

From headache to heartache: ergotamine-induced aortic and mitral valvulopathy.

Patel SM, Ohori NP, Badhwar V, Cavalcante JL.

J Am Coll Cardiol. 2013 Dec 3;62(22):2144. doi: 10.1016/j.jacc.2013.06.065. Epub 2013 Sep 22. No abstract available.

32.

Correlation of ultrasound findings with the Bethesda cytopathology classification for thyroid nodule fine-needle aspiration: a primer for radiologists.

Heller MT, Gilbert C, Ohori NP, Tublin ME.

AJR Am J Roentgenol. 2013 Sep;201(3):W487-94. doi: 10.2214/AJR.12.9071. Review.

PMID:
23971481
33.

"Colloid-rich" follicular neoplasm/suspicious for follicular neoplasm thyroid fine-needle aspiration specimens: cytologic, histologic, and molecular basis for considering an alternate view.

Ohori NP, Wolfe J, Hodak SP, LeBeau SO, Yip L, Carty SE, Duvvuri U, Schoedel KE, Nikiforova MN, Nikiforov YE.

Cancer Cytopathol. 2013 Dec;121(12):718-28. doi: 10.1002/cncy.21333. Epub 2013 Jul 23. Erratum in: Cancer Cytopathol. 2014 Dec;122(12):921.

34.

Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts.

Nikiforova MN, Khalid A, Fasanella KE, McGrath KM, Brand RE, Chennat JS, Slivka A, Zeh HJ, Zureikat AH, Krasinskas AM, Ohori NP, Schoedel KE, Navina S, Mantha GS, Pai RK, Singhi AD.

Mod Pathol. 2013 Nov;26(11):1478-87. doi: 10.1038/modpathol.2013.91. Epub 2013 Jun 7.

35.

RAS mutations in thyroid FNA specimens are highly predictive of predominantly low-risk follicular-pattern cancers.

Gupta N, Dasyam AK, Carty SE, Nikiforova MN, Ohori NP, Armstrong M, Yip L, LeBeau SO, McCoy KL, Coyne C, Stang MT, Johnson J, Ferris RL, Seethala R, Nikiforov YE, Hodak SP.

J Clin Endocrinol Metab. 2013 May;98(5):E914-22. doi: 10.1210/jc.2012-3396. Epub 2013 Mar 28.

36.

BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.

Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.

Cancer Cytopathol. 2013 Apr;121(4):197-205. doi: 10.1002/cncy.21229. Epub 2012 Aug 7.

37.

Intraoperative pathologic examination in the era of molecular testing for differentiated thyroid cancer.

McCoy KL, Carty SE, Armstrong MJ, Seethala RR, Ohori NP, Kabaker AS, Stang MT, Hodak SP, Nikiforov YE, Yip L.

J Am Coll Surg. 2012 Oct;215(4):546-54. doi: 10.1016/j.jamcollsurg.2012.05.027. Epub 2012 Jul 4.

PMID:
22766226
38.

Orbital metastasis as the initial presentation of invasive lobular carcinoma of breast.

Tomizawa Y, Ocque R, Ohori NP.

Intern Med. 2012;51(12):1635-8. Epub 2012 Jun 15.

40.

EUS-FNA mutational analysis in differentiating autoimmune pancreatitis and pancreatic cancer.

Khalid A, Dewitt J, Ohori NP, Chen JH, Fasanella KE, Sanders M, McGrath KM, Nikiforova M.

Pancreatology. 2011;11(5):482-6. doi: 10.1159/000331505. Epub 2011 Oct 11.

PMID:
21997479
41.

Selective screening for nongynecologic cytology specimens: modifying the screening process for improved efficiency and practice.

Marks-Jones DA, Sutkowski BA, Schoedel KE, Ohori NP.

Diagn Cytopathol. 2011 Oct;39(10):717-22. doi: 10.1002/dc.21449. Epub 2010 Nov 2.

PMID:
21919214
42.

Impact of mutational testing on the diagnosis and management of patients with cytologically indeterminate thyroid nodules: a prospective analysis of 1056 FNA samples.

Nikiforov YE, Ohori NP, Hodak SP, Carty SE, LeBeau SO, Ferris RL, Yip L, Seethala RR, Tublin ME, Stang MT, Coyne C, Johnson JT, Stewart AF, Nikiforova MN.

J Clin Endocrinol Metab. 2011 Nov;96(11):3390-7. doi: 10.1210/jc.2011-1469. Epub 2011 Aug 31.

43.

Usefulness of immunohistochemical and histochemical studies in the classification of lung adenocarcinoma and squamous cell carcinoma in cytologic specimens.

Ocque R, Tochigi N, Ohori NP, Dacic S.

Am J Clin Pathol. 2011 Jul;136(1):81-7. doi: 10.1309/AJCPFKOLGL6PMOF3.

PMID:
21685035
44.

Thyroid cytology: challenges in the pursuit of low-grade malignancies.

Ohori NP, Schoedel KE.

Radiol Clin North Am. 2011 May;49(3):435-51, v-vi. doi: 10.1016/j.rcl.2011.02.005. Review.

PMID:
21569903
45.

Bronchoscopic and transthoracic cytology and biopsy for pulmonary nonsmall cell carcinomas: performance characteristics by procedure and tumor type.

Tochigi N, Dacic S, Ohori NP.

Diagn Cytopathol. 2012 Aug;40(8):659-63. doi: 10.1002/dc.21588. Epub 2011 Feb 13.

PMID:
21319328
46.

Flow cytometric immunophenotyping of cerebrospinal fluid specimens.

Craig FE, Ohori NP, Gorrill TS, Swerdlow SH.

Am J Clin Pathol. 2011 Jan;135(1):22-34. doi: 10.1309/AJCPANA7ER1ABMZI.

PMID:
21173121
47.

DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.

Fasanella KE, Krasinskas A, Schoedel KE, Sasatomi E, Slivka A, Whitcomb DC, Sanders M, Nodit L, Raab S, McGrath KM, Ohori NP, Khalid A.

Pancreatology. 2010;10(4):429-33. doi: 10.1159/000318807. Epub 2010 Aug 19.

PMID:
20720444
48.

Focal monomorphic ventricular tachycardia as the first manifestation of amyloid cardiomyopathy.

Seethala S, Jain S, Ohori NP, Monaco S, Lacomis J, Crock F, Nemec J.

Indian Pacing Electrophysiol J. 2010 Mar 5;10(3):143-7.

49.

Contribution of molecular testing to thyroid fine-needle aspiration cytology of "follicular lesion of undetermined significance/atypia of undetermined significance".

Ohori NP, Nikiforova MN, Schoedel KE, LeBeau SO, Hodak SP, Seethala RR, Carty SE, Ogilvie JB, Yip L, Nikiforov YE.

Cancer Cytopathol. 2010 Feb 25;118(1):17-23. doi: 10.1002/cncy.20063.

50.

A novel complex BRAF mutation detected in a solid variant of papillary thyroid carcinoma.

Chiosea S, Nikiforova M, Zuo H, Ogilvie J, Gandhi M, Seethala RR, Ohori NP, Nikiforov Y.

Endocr Pathol. 2009 Summer;20(2):122-6. doi: 10.1007/s12022-009-9073-3.

PMID:
19370421

Supplemental Content

Loading ...
Support Center